indication for semaglutide Eligibility Across All Current Indications US Adults Semaglutide - Wikipedia

WattsNBBilezikianJPUsiskinKEdwardsRDesaiMLawGet al

Anti-obesity drug therapy can be offered as an adjunct to a reduced-calorie diet and increased physical activity for weight management in adult patients with an initial body mass index (BMI) of 30 kg/m 2 or 2730 kg/m 2 in the presence of at least one weight-related comorbidity, e.g., dysglycemia, hypertension, dyslipidemia, or obstructive sleep apnea

For commercially insured patients, most major carriers in Washington now cover at least one GLP-1 medication for weight management with prior authorization

Iwai S, Kaji K, Nishimura N, Kubo T, Tomooka F, Shibamoto A, Suzuki J, Tsuji Y, Fujinaga Y, Kitagawa K, Namisaki T, Akahane T, Yoshiji H

Race and genetic ancestry in medicine a time for reckoning with racism

Retatrutide is an investigational triple-hormone receptor agonist that mimics the biological effects of GLP-1, GIP, and glucagon, under investigation for its role in blood glucose regulation and weight modulation